AJM300

· EA Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AJM300, covering 2023-07-21 to 2023-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis [Phase 3]